期刊文献+

我国互联网药品交易政策的发展与监管研究 被引量:7

The Research on the Development and Regulation of Internet Drug Trading Policies of China
下载PDF
导出
摘要 目的:梳理我国互联网药品交易政策,为我国互联网药品交易监管提出相应建议。方法:通过国家食品药品监督管理总局(CFDA)网站,收集和整理我国互联网药品交易的相关政策,梳理我国互联网药品市场的演变历史和脉络,总结政策对于我国互联网药品交易的影响,并对当前监管工作中存在的问题进行分析。结果与结论:我国互联网药品监管政策对互联网药品交易的企业规模、药品种类以及物流运输方面都产生了深远影响。今后要继续完善法律法规、加强行业自律性建设、加强对网站的监督、运用信息化进行智能监管,促进我国互联网药品交易市场持续健康发展。 Objective: To make an analysis on the internet drug trading policies of China and to put forward corresponding suggestions for the regulation of the internet drug trading. Methods: The internet drug trading policies of China were collected from the CFDA website and were then organized. The historic evolution and context of the internet drug trading market were analyzed. The impact of policies on the internet drug trading of China was summarized. Moreover, the problems in current regulation were analyzed. Results and Conclusion: The regulatory policies for the internet drug trading has a profound impact on enterprise scale, drug category and logistics transportation. In future, laws and regulations should be improved, the construction of self-discipline and supervision of the websites should be strengthened, intelligent regulation should be carried out on the basis of information management so as to promote the sustainable and healthy development of the internet drug trading market in China.
出处 《中国药事》 CAS 2018年第2期161-166,共6页 Chinese Pharmaceutical Affairs
关键词 互联网 药品交易 监管政策 历史演变 企业规模 药品种类 物流运输 intemet drug trading regulatory policy historical evolution enterprise scale drug category logistics transportation
  • 相关文献

参考文献8

二级参考文献40

  • 1张欣涛,黄志禄,陈蕾,平其能.我国互联网药品信息监测工作的现状及对策分析[J].中国现代应用药学,2008,25(z2):776-778. 被引量:8
  • 2National Association of Boards of Pharmacy.Fees[EB/OL].[2010-06-10].Http://www.Nabp.Net/programs/accreditation/ vipps/ vipps-fees/.
  • 3National Association of Boards of Pharmacy.FAQs[EB/OL].[2010-06-10].Http://www.Nabp.Net/programs/accreditation/vipps/vipps-faqs/.
  • 4National Association of Boards of Pharmacy.NABP e-advertiser approval program application now available[EB/OL].(2010-04-21)[2010-06-10].Http://www.Nabp.Net/news/nabp-e-advertiser-approval-program-application-now-available/.
  • 5National Association of Boards of Pharmacy.Vermont news:the Ryan Haight online pharmacy consumer protection act[EB/OL].(2009-09-03)[2010-06-10].Http://www.Nabp.net/news/vermont-news-the-ryan-haight-online-pharmacy-consumer-protection-act/.
  • 6互联网药品信息服务信息管理办法[S].国家食品药品监督管理局令第9号,2004.
  • 7国家食品药品监督管理局.关于印发《互联网药品交易服务审批暂行规定》的通知[Z].国食药监市[2005]480号,2005.
  • 8工业及信息产业化部.关于建立境内违法互联网网站黑名单管理制度的通知[Z].工信部联电管[2009]371号,2009.
  • 9国家食品药品监督管理局.关于进一步严厉打击违法药品医疗器械保健食品广告的通知[Z].国食药监稽[2010]21号,2010.
  • 10中国互联网络信息中心.第28次中国互联网络发展状况统计报告[R/OL].(2011-07-19)[2011-10-27].http://www.cnnic.net.cn/dtygg/dtgg/201107/W020110719521725234632.pdf.

共引文献41

同被引文献68

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部